• No results found

Towards personalised treatment of patients with colorectal liver metastases

N/A
N/A
Protected

Academic year: 2021

Share "Towards personalised treatment of patients with colorectal liver metastases"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Towards personalised treatment of patients with colorectal liver metastases Hof, Joost

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Hof, J. (2019). Towards personalised treatment of patients with colorectal liver metastases. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

Download date: 28-06-2021

(2)

towards personalised treatment of patients with

colorectal liver metastases

JOOST HOF

(3)

Colofon

J. Hof

Towards personalised treatment of patients with colorectal liver metastases

ISBN online version 978-94-034-1319-8 ISBN printed version 978-94-034-1320-4

Layout and design by Matthijs Ariens, persoonlijkproefschrift.nl.

Printed by Ipskamp Printing, proefschriften.net.

This thesis was financially supported by the University Medical Center Groningen, Graduate School of Medical Sciences (University of Groningen), Junior Scientific Masterclass (University of Groningen), DEMCON advanced mechatronics, Pfizer B.V., Angiocare B.V.

and Bayer B.V.

Copyright © 2019 J. Hof

All rights reserved. No part of this thesis may be reproduced, stored or transmitted in any way or by any means without the prior permission of the author, or when applicable, of the publishers of the scientific papers.

(4)

Towards personalised treatment of patients with

colorectal liver metastases

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op woensdag 27 februari 2019 om 14.30 uur

door

Joost Hof

geboren op 8 december 1990 te Emmen

(5)

Promotores

Prof. dr. R.H. Sijmons Dr. K.P. de Jong

Copromotor Dr. K. Kok

Beoordelingscommissie Prof. dr. R.J. Porte

Prof. dr. J.H.M. van den Berg Prof. dr. J. Morreau

(6)

Paranimfen J. Osinga R. Modderman

(7)
(8)

Table of contents

Chapter 1 Introduction and outline of this thesis 9

Part I Association of biomarkers in resected colorectal liver metastases with patient survival

21

Chapter 2 Systematic review of the prognostic role of the immune system after surgery of colorectal liver metastases

Submitted manuscript

23

Chapter 3 B cell expression as prognostic biomarker after surgery for colorectal liver metastases

Submitted manuscript

49

Chapter 4 Low tumour expression of miR-19b and miR-196b predicts a good survival after surgery for colorectal liver metastases

Submitted manuscript

85

Chapter 5 Loss of chromosome 22 predicts a poor survival after surgery for colorectal liver metastases

Manuscript in preparation

101

Part II The role of thermal ablation in the management of patients with colorectal liver metastases

117

Chapter 6 Outcomes after resection and/or radiofrequency ablation for recurrences after treatment of colorectal liver metastases Br J Surg. 2016 Jul;103(8):1055-62.

119

Chapter 7 Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer PLoS One. 2018 Mar 15;13(3):e0193385.

139

Part III Overview and future 163

Chapter 8 Summary, discussion and future perspectives 165 Appendix Nederlandse samenvatting

Dankwoord Curriculum vitae

186 190 193

(9)

Referenties

GERELATEERDE DOCUMENTEN

On a lesion-by-lesion basis, the sensitivity and confidence levels in the detection of liver metastases, the ability to differentiate between malignant and benign focal

The sensitivity and specificity in the detection of colorectal liver metastases are similar for the thick-slice breath-hold T1-MPGE and thin-slice respiratory-triggered T1-MPGE.. The

To compare the formulas used to calculate the SDNR, we used fixed locations of metastasis and background noise ROIs: a homogeneous area at the margin of the metastasis

In summary, soft-copy evaluation for contrast-enhanced CT data sets for the detection of colorectal hepatic metastases and extrahepatic metastatic recurrence is significantly

Bartlett et al [12] reported a response rate of 74 percent, a median time to progression of 14.5 months and a median survival of 27 months after IHP with 1.5 mg/kg

The signal intensities (SI) of 48 liver metastases (originating from colorectal cancer) in 20 patients, the surrounding liver parenchyma and the background noise

Geconcludeerd mag worden dat de “ soft-copy” beoordeling van de series na toediening van intraveneus contrastmiddel voor de detectie van uitzaaiingen in en buiten de lever

Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients